DE69931784D1 - Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung - Google Patents

Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung

Info

Publication number
DE69931784D1
DE69931784D1 DE69931784T DE69931784T DE69931784D1 DE 69931784 D1 DE69931784 D1 DE 69931784D1 DE 69931784 T DE69931784 T DE 69931784T DE 69931784 T DE69931784 T DE 69931784T DE 69931784 D1 DE69931784 D1 DE 69931784D1
Authority
DE
Germany
Prior art keywords
chips
chemotaxis
staphylococcus aureus
inhibiting protein
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69931784T
Other languages
English (en)
Other versions
DE69931784T2 (de
Inventor
Strijp Antonius Van
Kessel Petrus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alligator Bioscience AB
Original Assignee
Alligator Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alligator Bioscience AB filed Critical Alligator Bioscience AB
Application granted granted Critical
Publication of DE69931784D1 publication Critical patent/DE69931784D1/de
Publication of DE69931784T2 publication Critical patent/DE69931784T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69931784T 1998-07-10 1999-07-12 Chemotaxishemmendes protein von staphylococcus aureus (chips) und dessen verwendung Expired - Lifetime DE69931784T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL1009614 1998-07-10
NL1009614 1998-07-10
PCT/NL1999/000442 WO2000002913A1 (en) 1998-07-10 1999-07-12 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use

Publications (2)

Publication Number Publication Date
DE69931784D1 true DE69931784D1 (de) 2006-07-20
DE69931784T2 DE69931784T2 (de) 2007-06-14

Family

ID=19767471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931784T Expired - Lifetime DE69931784T2 (de) 1998-07-10 1999-07-12 Chemotaxishemmendes protein von staphylococcus aureus (chips) und dessen verwendung

Country Status (22)

Country Link
US (2) US20050143307A1 (de)
EP (1) EP1095059B1 (de)
JP (1) JP2002520336A (de)
KR (1) KR20010053290A (de)
CN (1) CN1309662A (de)
AT (1) ATE328898T1 (de)
AU (1) AU4935999A (de)
BG (1) BG105120A (de)
BR (1) BR9911944A (de)
CA (1) CA2333898A1 (de)
CY (1) CY1105343T1 (de)
DE (1) DE69931784T2 (de)
DK (1) DK1095059T3 (de)
ES (1) ES2270609T3 (de)
HU (1) HUP0102975A2 (de)
IL (1) IL140768A0 (de)
NO (1) NO20010140L (de)
NZ (1) NZ509051A (de)
PL (1) PL345452A1 (de)
PT (1) PT1095059E (de)
WO (1) WO2000002913A1 (de)
ZA (1) ZA200100092B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ509051A (en) * 1998-07-10 2003-01-31 Jari Pharmaceuticals B Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
EP1118663A1 (de) * 2000-01-07 2001-07-25 Universiteit Utrecht Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
WO2005005630A2 (en) * 2003-07-08 2005-01-20 Umc Utrecht Holding B.V. Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases
EP1586583A3 (de) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Substanzen die der C5a Komplementrezeptor blockieren und deren Verwendung in der Therapie
EP1778882A2 (de) 2004-07-26 2007-05-02 State of Israel, Department of Agriculture, Kimron Veterinary Institute Neue bakterien und daraus gewonnene pharmazeutisch wirksame produkte
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) * 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
WO1993004202A1 (en) * 1991-08-22 1993-03-04 Washington University Polynucleotide probes for salmonella
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5514455A (en) * 1994-07-08 1996-05-07 Union Carbide Chemicals & Plastics Technology Corporation Film extruded from an in situ blend of ethylene copolymers
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
US7153655B2 (en) * 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
NZ509051A (en) * 1998-07-10 2003-01-31 Jari Pharmaceuticals B Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
JP3722194B2 (ja) * 1999-05-20 2005-11-30 セイコーエプソン株式会社 画像表示システム
EP1118663A1 (de) * 2000-01-07 2001-07-25 Universiteit Utrecht Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) * 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
WO2003097834A2 (en) * 2002-05-17 2003-11-27 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function

Also Published As

Publication number Publication date
EP1095059B1 (de) 2006-06-07
DE69931784T2 (de) 2007-06-14
ES2270609T3 (es) 2007-04-01
BG105120A (en) 2001-11-30
NO20010140L (no) 2001-03-01
AU4935999A (en) 2000-02-01
BR9911944A (pt) 2001-09-25
PT1095059E (pt) 2006-10-31
IL140768A0 (en) 2002-02-10
CN1309662A (zh) 2001-08-22
ATE328898T1 (de) 2006-06-15
PL345452A1 (en) 2001-12-17
WO2000002913B1 (en) 2000-03-30
CA2333898A1 (en) 2000-01-20
HUP0102975A2 (hu) 2001-11-28
DK1095059T3 (da) 2006-10-02
EP1095059A1 (de) 2001-05-02
ZA200100092B (en) 2001-07-23
NO20010140D0 (no) 2001-01-09
CY1105343T1 (el) 2010-03-03
JP2002520336A (ja) 2002-07-09
WO2000002913A1 (en) 2000-01-20
KR20010053290A (ko) 2001-06-25
NZ509051A (en) 2003-01-31
US20080242605A1 (en) 2008-10-02
US20050143307A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE233274T1 (de) Oxyiminopregnancarbolactone
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
NO990667D0 (no) Depeptid-benzamidin som kinogenase-inhibitor
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
ATE433963T1 (de) Fab-i inhibitoren
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
DK0804465T3 (da) Nye elastaseinhibitorer
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
SE9903290D0 (sv) Novel compounds
NO20053562L (no) Nye aminobenzofenonforbindelser
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
PT1232173E (pt) Derivados do acido fusidico
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition